DigestRedComo funciona
Red
/
Empresas
Ka
No verificado

Kairos Pharma, Ltd

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaOncologíaSalud

34 Comunicados de prensa

Ver todos los comunicados de prensa
09/09/2026
Web y redes sociales
Eventos
Salud
Ciencia
Farmacéutica
Oncología
Kairos Pharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
21/08/2026
Finanzas
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma Announces 1-for-7 Reverse Stock Split
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
22/07/2026
Mercado laboral
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Kairos Pharma Announces Strategic Collaboration with Bayer to Enhance XOFIGO Activity in Metastatic Prostate Cancer
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
15/07/2026
Industria
Farmacéutica
Salud
Oncología
Medicina - Varios
Kairos Pharma Reports Breakthrough Interim Safety Data in Phase 1 Trial of ENV-105 in EGFR-Mutated Lung Cancer Patients — Targeting a $10 Billion Drug Resistance Market
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
04/06/2026
Oncología
Salud
Medicina - Varios
Ciencia
Biotecnología
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
14/05/2026
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma Receives GHP Magazine’s Healthcare & Pharmaceutical Award
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
08/05/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma, Ltd. Sets Annual Meeting of Shareholder Date and Provides Update on Its Annual Filings
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
15/04/2026
Eventos
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma Recognized with Pinnacle Award for Excellence in Healthcare Innovation
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
02/03/2026
Mercado laboral
Software
Biotecnología
Farmacéutica
Oncología
Salud
Técnica
Medicina - Varios
Kairos Pharma Announces Signing of Binding Strategic Asset Acquisition of Exclusive Worldwide Rights to CL-273 From OrbiMed and Torrey Pines Investment-Backed Celyn Therapeutics
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0
26/02/2026
Mercado de valores
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Kairos Pharma, Ltd. Announces Signing of Term Sheet for Strategic Asset Acquisition of Two Clinical Oncology Assets from Celyn Therapeutics
Fuente
Kairos Pharma, Ltd
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0